The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 147,441 | 141,957 | 136,564 | 119,802 | 104,406 |
| Cost of Goods | 124,126 | 119,192 | 117,644 | 102,301 | 87,157 |
| Gross Profit | 23,315 | 22,765 | 18,920 | 17,501 | 17,249 |
| Operating Expenses | 29,954 | 29,864 | 27,618 | 29,013 | 27,317 |
| Operating Income | -6,513 | -6,907 | -8,054 | -11,211 | -9,911 |
| Interest Expense | 1,934 | 1,916 | 1,920 | 1,870 | 5,570 |
| Other Income | 5,955 | 1,315 | -6,530 | -4,059 | -4,104 |
| Pre-tax Income | -2,492 | -7,508 | -16,504 | -17,140 | -19,585 |
| Income Tax | N/A | N/A | N/A | -131 | N/A |
| Net Income Continuous | -2,492 | -7,508 | -16,504 | -17,009 | -19,585 |
| Net Income | $-2,492 | $-7,508 | $-16,504 | $-17,009 | $-19,585 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.17 | -0.18 | -0.25 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.17 | -0.18 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.06 | -0.14 | -0.15 | -0.18 |
| EBITDA(a) | $-3,686 | $-4,070 | $-5,159 | $-8,277 | $-3,253 |